Tandem Diabetes Care, Inc. Stock
Equities
TNDM
US8753722037
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.9 USD | +2.26% | +12.01% | +78.84% |
Financials (USD)
Sales 2024 * | 868M | Sales 2025 * | 959M | Capitalization | 3.34B |
---|---|---|---|---|---|
Net income 2024 * | -108M | Net income 2025 * | -71M | EV / Sales 2024 * | 3.68 x |
Net cash position 2024 * | 145M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 3.37 x |
P/E ratio 2024 * |
-32
x | P/E ratio 2025 * |
-48
x | Employees | 2,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on Tandem Diabetes Care, Inc.
1 day | +2.26% | ||
1 week | +12.01% | ||
Current month | +44.18% | ||
1 month | +50.11% | ||
3 months | +93.49% | ||
6 months | +171.70% | ||
Current year | +78.84% |
Managers | Title | Age | Since |
---|---|---|---|
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
Leigh Vosseller
DFI | Director of Finance/CFO | 51 | 13-08-31 |
Shannon Hansen
CMP | Compliance Officer | 58 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 19-01-02 | |
Director/Board Member | 64 | 13-06-30 | |
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.45% | 2 M€ | 0.00% | ||
0.32% | 430 M€ | -.--% | ||
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 52.9 | +2.26% | 1,103,635 |
24-05-24 | 51.73 | +4.13% | 1,037,730 |
24-05-23 | 49.68 | -3.33% | 1,536,843 |
24-05-22 | 51.39 | +4.20% | 2,053,182 |
24-05-21 | 49.32 | +4.43% | 4,899,236 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+78.84% | 3.34B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+3.49% | 40.74B | |
+19.92% | 31.6B | |
+16.38% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- TNDM Stock